<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03459508</url>
  </required_header>
  <id_info>
    <org_study_id>N-2aa5-2018</org_study_id>
    <nct_id>NCT03459508</nct_id>
  </id_info>
  <brief_title>Ocular Findings in Women With Primary Antiphospholipid Syndrome</brief_title>
  <official_title>Ocular Findings in Women With Primary Antiphospholipid Syndrome and Their Association to Bad Obstetric Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <brief_summary>
    <textblock>
      Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by systemic
      thrombosis and bad obstetric history. APS secondary to another medical disorder is the most
      common. Visual and ocular changes e.g. vaso-occlusive disease of retinal and choroidal
      vessels are found in patients with secondary APS. Patients with primary APS have also been
      reported to have ocular changes e.g. retinal vascular occlusion

      The aim of our study to detect prevalence of ocular changes in women diagnosed with primary
      APS and correlation of these changes with adverse obstetric outcome. If a correlation is
      present, ocular findings in women with APS could be used in the future as a predictor for
      poor obstetric outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of Ocular changes in females with antiphospholipid syndrome</measure>
    <time_frame>On the same day of enrollment into the study</time_frame>
    <description>Number of participants with ocular findings detected by ophthalmological examination</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Primary Antiphospholipid Syndrome</condition>
  <arm_group>
    <arm_group_label>Primary antiphospholipid syndrome women</arm_group_label>
    <description>Informed consent
Detailed history emphasizing on
a. obstetric complications related to antiphospholipid syndrome: i. Recurrent miscarriage ii. Fetal demise iii. Fetal growth restriction iv. Severe pre-eclampsia or eclampsia v. Placental insufficiency vi. Placental abruption b. Systemic vascular complications related to antiphospholipid syndrome: i. Arterial thrombosis ii. Venous thrombosis iii. Small-vessel thrombosis
Revision of diagnosis of primary antiphospholipid syndrome:
Exclusion of antiphospholipid syndrome secondary to SLE and other autoimmune diseases by: antinuclear (ANA), anti-Smith (Sm) and anti-double stranded DNA (dsDNA) antibodies.
Ophthalmological examination:</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ophthalmological examination</intervention_name>
    <description>Detailed anterior segment examination using slit-lamp biomicroscopy for signs of anterior uveitis, and detailed fundus examination using slit-lamp fundus biomicroscopy with + 90 diopter lens searching for signs of vasculitis and posterior uveitis.</description>
    <arm_group_label>Primary antiphospholipid syndrome women</arm_group_label>
    <other_name>slit lamp biomicroscopy</other_name>
    <other_name>slit lamp exam</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients (inpatient or outpatient) with primary antiphospholipid syndrome at
        Kasr-Alainy hospital (The Cairo University Hospital)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 18 to 35 years

          -  Females with primary antiphospholipid syndrome

        Exclusion Criteria:

          -  Age: below 18 years and above 35 years

          -  Auto-immune diseases e.g. SLE and other connective tissue disease

          -  Medical diseases causing retinal vascular changes e.g. hypertension, diabetes
             mellitus, sickle cell anemia.

          -  Previous vitreo-retinal surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed AA Wali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed AA Wali, MD</last_name>
    <phone>01001735088</phone>
    <phone_ext>+2</phone_ext>
    <email>ahmed.wali@kasralainy.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed AA Wali, MD</last_name>
      <phone>01001735088</phone>
      <phone_ext>+2</phone_ext>
      <email>ahmed.wali@kasralainy.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Mohamed AM Attya, MD</last_name>
      <phone>01113332892</phone>
      <phone_ext>+2</phone_ext>
      <email>mohamed.attya@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Ahmed AA Wali, MD</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>Antiphospholipid Syndrome - Bad obstetric history - Ocular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Antiphospholipid Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

